Ionis Pharmaceuticals (NASDAQ:IONS) prices $500M aggregate principal amount of 1.75% convertible senior notes due 2028 in a private placement to qualified institutional buyers. The initial purchasers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback